Venetoclax and the future of treatment of multiple myeloma
Prof. Ken Anderson on opportunities in myeloma research and his lifetime achievement award
COMy 2017: Day 2 discussion on relapsed myeloma, treatment, plasma cell leukemia and awards
Arnon Nagler et al.
Can venetoclax be used to treat multiple myeloma (MM)?
The epigenetics of multiple myeloma and the rationale for HDAC inhibitors